Stockscreener 앱 받기
0.9993
25.98%
-0.3507
시장 영업 전:
1.03
0.0307
+3.07%
전일 마감가:
$1.35
열려 있는:
$1.22
하루 거래량:
2.09M
Relative Volume:
13.44
시가총액:
$7.54M
수익:
-
순이익/손실:
$-19.92M
주가수익비율:
-0.2339
EPS:
-4.2716
순현금흐름:
$-20.51M
1주 성능:
-34.26%
1개월 성능:
-53.74%
6개월 성능:
-11.57%
1년 성능:
-65.66%
1일 변동 폭
$0.98
$1.23
1주일 범위
$0.82
$2.09
52주 변동 폭
$0.82
$2.31
Biovie Inc Stock (BIVI) Company Profile
명칭
Biovie Inc
전화
775-888-3162
주소
680 W NYE LANE, CARSON CITY
Compare BIVI vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
0.9993 | 10.33M | 0 | -19.92M | -20.51M | -4.2716 |
VRTX
Vertex Pharmaceuticals Inc
|
496.07 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
784.36 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
865.04 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
205.15 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
348.27 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-07-22 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-15 | 개시 | B. Riley Securities | Buy |
Biovie Inc 주식(BIVI)의 최신 뉴스
BioVie Inc (BIVI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioVie Inc (BIVI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BIVI|BioVie Inc|Price:1.400|Chg%:+0.030 - TradingKey
BIVI|BioVie Inc|Price:1.370| - TradingKey
BioVie Inc (BIVI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioVie Inc (BIVI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
TradingKey - TradingKey
BioVie Inc (BIVI) Income Statement - TradingKey
BioVie Inc (BIVI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioVie Inc (BIVI) Balance Sheet - TradingKey
BioVie Inc. Revenue Breakdown – NASDAQ:BIVI - TradingView
BIVI|BioVie Inc|Price:1.370|Chg%:-0.070 - TradingKey
BioVie Warrants (BIVIW) Hold Steady at $0.53 Amid Tight Trading RangeStrangle Setup - dars.gov.et
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Sahm
Daily Brief Health Care: JPJ (TCM) Limited(TCM), Abeona Therapeutics , Mani Inc, BioVie , Propanc Biopharma, Tivic Health Systems Inc and more - Smartkarma
IPO Databook: Biovie (BIVI US)Jul 2026 - Smartkarma
BioVie Files for a Stock Offering - Moomoo
[S-1] BIOVIE INC. Files IPO Registration Statement - Stock Titan
Form S-1 Biovie Inc For: 17 July By Investing.com - Investing.com UK
BIVIW SEC FilingsBiovie Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Enterprise value to EBIT forward of BioVie Inc. – NASDAQ:BIVIW - TradingView
บทสัมภาษณ์ของ Foremost Clean Energy และ BioVie เตรียมออกอากาศในรายการ RedChip Small Stocks, Big Money(TM) ทางสถานีโทรทัศน์ Bloomberg TV - Moomoo
BioVie Inc. Warrants (BIVIW) Trade Flat Near Key Levels – What to WatchHedge Fund Favorites - dars.gov.et
BioVie Inc Warrant 2025-01.06.30 on BioVie Financial Disclosures & SEC Filings - TradingView
Price to earnings forward of BioVie Inc. – NASDAQ:BIVI - TradingView
Price to sales forward of BioVie Inc. – NASDAQ:BIVI - TradingView
Price to book forward of BioVie Inc. – NASDAQ:BIVI - TradingView
Enterprise value to revenue forward of BioVie Inc. – NASDAQ:BIVI - TradingView
Enterprise value to EBITDA forward of BioVie Inc. – NASDAQ:BIVI - TradingView
Enterprise value to EBIT forward of BioVie Inc. – NASDAQ:BIVI - TradingView
BioVie Inc. Class A Financial Disclosures & SEC Filings - TradingView
[EFFECT] BIOVIE INC. SEC Filing - Stock Titan
BioVie Inc. (BIVI) Climbs 3.6% as Shares Test Key Resistance Near $2.11Opening Range Breakout - dars.gov.et
BioVie Inc. Class A Actuals & Estimates (NASDAQ:BIVI) - TradingView
BIVI Q1 2026 Earnings: EPS Beats Estimates as Drug Development ProgressesEarnings Per Share - dars.gov.et
BioVie | 4: Statement of changes in beneficial ownership of securities-Officer DO CUONG V - Moomoo
BIVI Forecast — Price Target — Prediction for 2027 - TradingView
BIVI Q1 2026 Earnings: EPS Beat on Narrower-Than-Expected Loss; Stock Slightly DownEarnings Momentum Score - dars.gov.et
BioVie Inc. Q1 2026 Earnings: Narrower-than-Expected Loss as Biotech Advances PipelineQuarterly Financial Update - DonanımHaber
BioVie Inc. (BIVI) Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Growth Report - dars.gov.et
Biovie Files To Offer Up To $300 Million In SecuritiesSEC Filing - TradingView
BioVie (NASDAQ: BIVI) files $300M shelf registration to sell securities - Stock Titan
BioVie Inc (BIVI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioVie Inc (BIVI) Institutional Confidence - TradingKey
BioVie Inc (BIVI) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioVie Inc (BIVI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BIVI Q1 2026 Earnings: EPS Beat Driven by Lower-than-Expected Operating ExpensesAdjusted Earnings Analysis - newsline.com
BIVI Q1 2026 Earnings: Narrower Loss Than Expected as Pipeline Progress ContinuesEnergy Earnings Report - newsline.com
BIVI Q1 2026 Earnings: EPS Beat Amid Clinical Progress; Stock DeclinesShare Repurchase Impact - newsline.com
Did BioVie Inc. Insiders Breach their Fiduciary Duties to Shareh - GuruFocus
Law firm investigates BioVie officers for possible breach of duties to shareholders - Pluang
Biovie Inc (BIVI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.86%
자본화:
|
볼륨(24시간):